These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1100957)

  • 1. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

  • 4. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
    Rohde R
    Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
    Hamzah M; Kosasih A
    Lepr Rev; 1975 Jun; 46(2 Suppl):181-7. PubMed ID: 1100959
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
    Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
    Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 12. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
    Depasquale G
    Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First assessment of the Malta Leprosy Eradication Project.
    Leiker DL
    Lepr Rev; 1986; 57 Suppl 3():42-6. PubMed ID: 3573959
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
    Chum HJ
    Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
    [No Abstract]   [Full Text] [Related]  

  • 16. Prothionamide and prothionamide-S-oxide in experimental leprosy.
    Matsuo Y; Tatsukawa H; Murray JF; Peters JH
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
    Dietrich M; Wabitsch R
    Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
    [No Abstract]   [Full Text] [Related]  

  • 18. Multi-drug therapy of leprosy.
    Ramu G
    Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
    [No Abstract]   [Full Text] [Related]  

  • 19. [New drugs in the treatment of leprosy].
    De Las Aguas JT
    Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the joint leprosy-tuberculosis project in Paraguay.
    Alvarenga AE
    Lepr Rev; 1986; 57 Suppl 3():53-9. PubMed ID: 3573961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.